Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy
- PMID: 28083037
- PMCID: PMC5216293
- DOI: 10.12669/pjms.326.10917
Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy
Abstract
Background and objectives: Hypertensive disorder in pregnancy is the significant disease that badly affects the maternal and fetal prognosis and lead to higher mortality and morbidity in the prenatal period. Visfatin, potentially a new adipokine has emerged having high contribution in pathogenesis of pre-eclampsia. The objective of the study was to find the level of Visfatin in pregnancy induced hypertension and normal pregnant women.
Methods: This study was carried out in tertiary care hospitals, Peshawar from March-October 2014. A total of 234 pregnant women (gestational age >20 weeks) were included in the study with distribution as Preeclampsia (PE=86), Eclampsia (E=74) and control (N=74). Blood was taken for measuring Visfatin level by Enzyme Linked Immunosorbent Assay (ELISA) technique. SPSS version 19 was used for statistical analysis. Student's t test was performed to evaluate the mean differences in patients and control.
Results: Serum level of visfatin was significantly higher in pregnancy induced hypertension when compared with control (P value<0.001).: Comparisons of mean value of visfatin with age group of 21-40 years, body mass index (BMI), primary parous and parity 2-4, gestational age of >36 weeks and both systolic and diastolic blood pressure were highly significant in pregnancy induced hypertension when compared with control (p value<0.001).
Conclusion: Pregnancy induced hypertensive women showed increased level of serum Visfatin than normal pregnant women.
Keywords: Eclampsia; Hypertension; Normotensive pregnant women; Pre-eclampsia; Pregnancy; Visfatin.
Conflict of interest statement
Declaration of interest: The authors declare that they have no competing interests.
Figures
References
-
- Watanabe K, Naruse K, Tanaka K, Metoki H, Suzuki Y. Outline of definition and classification of “pregnancy induced hypertension (PIH)”. Hypertension Research in Pregnancy. 2013;1(1):3–4.
-
- WHO. The World Health Report 2005: Make every mother and child count. Geneva, Switzerland: 2005. - PubMed
-
- Bagga R, Aggarwal N, Chopra V, Saha SC, Prasad GR, Dhaliwal LK. Pregnancy complicated by severe chronic hypertension: a 10-year analysis from a developing country. Hypertens Pregnancy. 2007;26(2):139–149. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources